MedPath

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Recruiting
Conditions
Cholangiocarcinoma
Gallbladder Cancer
Pancreas Cancer
Interventions
Other: Measurement of triceps skinfold thickness
Registration Number
NCT03637569
Lead Sponsor
Samsung Medical Center
Brief Summary

In this study, the investigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.

Detailed Description

Cachexia is frequently seen in pancreatic cancer(70-80%) and associated with reduced survival, reduced treatment tolerance and reduction in QoL. In recent studies, low-normal BMI have worse outcome (overall mortality) in cardiovascular, malignant, chronic disease (So called "obesity paradox") BMI is simple method but hard to define body composition because BMI is based on only weight and height. Skinfold thickness is strongly associated with body fatness than BMI. In this study, the ivestigators aim to demonstration of relationship between triceps skinfold thickness and overall survival of pancreatic cancer, cholangiocarcinoma and GB cancer.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoing therapeutic management (including surgery, chemotherapy or palliative care).
  • Age above 18 years old
Exclusion Criteria
  • Other malignant disease
  • Underlying intestinal disease that cause absorprtion disorder
  • Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cancer patientsMeasurement of triceps skinfold thicknessNewly diagnosed pancreatic, bile duct or GB cancer patients at samsung medical center.
Primary Outcome Measures
NameTimeMethod
Overall survivalthrough study completion, an average of 2 year

The duration between diagnosis and death

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath